IVEG Webcast
The long-term impact of the pandemic in the management of retinal pathologies: what we have learned, what we have changed
Live pageFloretina and ICOOR Joint Meeting 2021
Watch nowExperts Arena: The Debate on Fluid Tolerance
Watch nowWhat is on the Horizon? A Symposium on the future of ophthalmology at Euretina 2021
Read nowBehind the mask: maintaining clear communication amid the pandemic
Watch nowCataract Surgery after lens trauma from intravitreal injections
Watch nowA video journey in the “new normal” of retina practices
Watch nowRemote monitoring with Home OCT
Watch nowWhat is on the Horizon? A Symposium on the future of ophthalmology at Euretina 2021
Home monitoring, intravitreal treatments, gene therapy, AI. The future of ophthalmology through the
Euretina 2021 Virtual Congress
Behind the mask: maintaining clear communication amid the pandemic
A complicated matter of doctor-patient communication during COVID-19 times.
Mucormycosis and COVID-19 in India: a warning from Prof. Natarajan
Prof. Natarajan warns his colleagues and patients in India against mucormycosis.
A video journey in the “new normal” of retina practices
Timely detection of wet AMD with remote home screening
Data from a retrospective real world study highlights low incidence of proactive treatment of nAMD
Managing retina patient flow in the COVID-19 era
Patients wearing face masks during intravitreal injections may be at higher risk of endophthalmitis, study shows.
Study warns about the use of masks by patients during intravitreal injections.
The Good, the Bad and The Ugly of the New Pandemic Life
COVID-19 era, how to smartly and efficiently adapt to the new challenges.
COVID-19 impact on clinical trials: the case of XTEND
Varun Chaudhary presented data about patient enrolment in XTEND during the peak of the pandemic.
There are still more questions than answers on COVID-related ocular findings
Study shows how impact of COVID-19 may affect the eye, but medium and long terms effects are still t
Remote monitoring in the management of retinal disease
Ashar Agarwal, COVID-19 situation and eye care in India
A detailed update on the COVID situation and eye care in India
Managing retina units before and after the lockdown
SriniVas Sadda talks about the management of retinal ophthalmology during and after the lockdown.
Steps for safe injections in the time of COVID-19
Jordi Monés, MD, PhD shows steps for safe injections in the time of COVID-19
Intravitreal therapy during the pandemic, reassuring patients.
Francesco Bandello MD, FEBO, raises awareness on the need for ophthalmologists to reassure patients
Current Knowledge about SARS-CoV-2 Infection
COVID-19, a challenge to our creativity and humanity
Anti-VEGF therapies for AMD: where are we now?
Where are we now with the spread of these therapies for AMD to prevent blindness?
LEARN MOREDefining Nonadherence and Nonpersistence to Anti-VEGF Therapies in nAMD
The nAMD Barometer Leadership Coalition published a definition for nonadherence and nonpersistence to anti-VEGF.
LEARN MOREWhat is on the Horizon? A Symposium on the future of ophthalmology at Euretina 2021
Home monitoring, intravitreal treatments, gene therapy, AI. The future of ophthalmology through the eyes of international thought leaders.
LEARN MOREBehind the mask: maintaining clear communication amid the pandemic
A complicated matter of doctor-patient communication during COVID-19 times.
LEARN MOREAbout us
a panel of top-tier international vitreoretinal surgeons
The experience shared by this group of professionals is aligned with their mission to promote and provide best practice recommendations
Only modern and best equipment advanced medical technologies and innovative diagnosis and treatment methods and technology.
Our organization has received a financial education grant from Bayer. Bayer has had no influence on this website content.